Loading…
Based on limited metadata without access to the full warning letter text, Kegan Wellness, a drug manufacturer or distributor, received an FDA warning on July 13, 2020 regarding violations of FDA regulations. While specific violation details are not available in the metadata provided, the warning falls under FDA's drug product oversight and enforcement authority. Without the complete letter subject line and violation descriptions, the exact nature of the compliance issues cannot be determined from this information alone.